Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study

被引:13
|
作者
Peng, Juan [1 ]
Zhang, Yan [2 ,3 ]
Zhu, Yiqun [2 ]
Chen, Weilin [1 ,4 ]
Chen, Li [1 ,4 ]
Ma, Fangyu [5 ]
Yi, Bin [1 ,4 ]
Huang, Zhijun [1 ,4 ,6 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Branch Natl Clin Res Ctr Resp Dis, Dept Resp Med,Natl Key Clin Specialty, Changsha, Hunan, Peoples R China
[3] Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China
[4] Clin Res Ctr Crit Kidney Dis Hunan Prov, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China
[6] Furong Lab, Changsha, Hunan, Peoples R China
来源
BMC MEDICINE | 2024年 / 22卷 / 01期
关键词
Estimated glucose disposal rate; Chronic kidney disease; Cardiovascular events; Mortality; INSULIN-RESISTANCE; INFLAMMATION; ASSOCIATION; MUSCLE;
D O I
10.1186/s12916-024-03582-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Evidence suggests that insulin resistance (IR) is an autonomous risk factor for cardiovascular disease (CVD). Nevertheless, the association between estimated glucose disposal rate (eGDR), a novel indicator of IR, and incident CVD and mortality in chronic kidney disease (CKD) patients without diabetes remains uncertain. Methods The study included 19,906 participants from the UK Biobank who had an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m(2) or a urinary albumin-to-creatinine ratio (UACR) >= 30 mg/g and no history of CVD and diabetes. Individuals were divided into three categories based on tertiles of eGDR. The outcome was a composite CVD (coronary heart disease (CHD) and stroke) and mortality (all-cause, non-accidental, and cardiovascular mortality). Furthermore, a cohort of 1,600 individuals from the US National Health and Nutrition Examination Survey (NHANES) was applied to validate the association between eGDR and mortality. The Cox proportional hazards regression models were used to examine the association between eGDR and event outcomes. Results During a follow-up of around 12 years, 2,860 CVD, 2,249 CHD, 783 stroke, 2,431 all-cause, 2,326 non-accidental and 492 cardiovascular deaths were recorded from UK Biobank. Higher eGDR level was not only associated with lower risk of CVD (hazard ratio [HR] 0.641, 95% confidence interval [CI] 0.559-0.734), CHD (HR 0.607, 95% CI 0.520-0.709), stroke (HR 0.748, 95% CI 0.579-0.966), but also related to reduced risk of all-cause (HR 0.803, 95% CI 0.698-0.923), non-accidental (HR 0.787, 95% CI 0.682-0.908), and cardiovascular mortality (HR 0.592, 95% CI 0.423-0.829). Validation analyses from NHANES yielded consistent relationship on mortality. Conclusions In these two large cohorts of CKD patients without DM, a higher eGDR level was associated with a decreased risk of CVD and mortality.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Estimated glucose processing rates and the association of chronic kidney disease and proteinuria in non-diabetic adults
    Zhou, Hao
    Ru, Xuanwen
    Chen, Simiao
    Ye, Qing
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025,
  • [2] The role of cardiovascular disease in the association between estimated glucose disposal rate and chronic kidney disease
    Chen, Yihuan
    Zheng, Lei
    Zhou, Ying
    Hou, Yucheng
    Zhou, Yihong
    Shen, Han
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [3] The predictive value of estimated glucose disposal rate for all-cause and cardiovascular mortality in the US non-diabetic population aged ≥60 years: A population-based cohort study
    Zhu, Botao
    Cao, Chenghui
    Liu, Wenwu
    Liu, Yuxuan
    Luo, Yonghong
    Peng, Daoquan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2025, 19 (01)
  • [4] Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
    Quiroga, Borja
    Munoz Ramos, Patricia
    Sanchez Horrillo, Ana
    Ortiz, Alberto
    Manuel Valdivieso, Jose
    Carrero, Juan Jesus
    CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1705 - 1712
  • [5] Estimated glucose disposal rate and risk of cardiovascular disease and mortality in US adults with prediabetes: a nationwide cross-sectional and prospective cohort study
    Kong, Xiufang
    Wang, Wei
    ACTA DIABETOLOGICA, 2024, 61 (11) : 1413 - 1421
  • [6] Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study
    Masaaki Nakayama
    Toshinobu Sato
    Mariko Miyazaki
    Masato Matsushima
    Hiroshi Sato
    Yoshio Taguma
    Sadayoshi Ito
    Hypertension Research, 2011, 34 : 1106 - 1110
  • [7] Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study
    Shiyi Tao
    Lintong Yu
    Jun Li
    Ji Wu
    Xuanchun Huang
    Zicong Xie
    Tiantian Xue
    Yonghao Li
    Lilan Su
    Cardiovascular Diabetology, 24 (1)
  • [8] Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study
    Nakayama, Masaaki
    Sato, Toshinobu
    Miyazaki, Mariko
    Matsushima, Masato
    Sato, Hiroshi
    Taguma, Yoshio
    Ito, Sadayoshi
    HYPERTENSION RESEARCH, 2011, 34 (10) : 1106 - 1110
  • [9] Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study
    Chen, Shengnan
    Chen, Lei
    Jiang, Hongli
    RENAL FAILURE, 2022, 44 (01) : 1309 - 1318
  • [10] Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study
    Chen, Yuwen
    Lian, Wenbin
    Wu, Lunzhe
    Huang, An'an
    Zhang, Deliang
    Liu, Bingchen
    Qiu, Yuangang
    Wei, Qucheng
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)